Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection. 2010

Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
Department of Experimental Immunology, Sanquin Research, Landsteiner Laboratory, Department of Medical Microbiology, part of the Center for Infectious Diseases and Immunity Amsterdam (CINIMA) at the Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.

The HIV-1 quasispecies in peripheral blood mononuclear cells (PBMC) is considered to be a mix of actively replicating, latent, and archived viruses and may be genetically distinct from HIV-1 variants in plasma that are considered to be recently produced. Here we analyzed the genetic relationship between gp160 env sequences from replication competent clonal HIV-1 variants that were isolated from PBMC and from contemporaneous HIV-1 RNA in serum and HIV-1 proviral DNA in PBMC of four longitudinally studied therapy naïve HIV-1 infected individuals. Replication competent clonal HIV-1 variants, HIV-1 RNA from serum, and HIV-1 proviral DNA from PBMC formed a single virus population at most time points analyzed. However, an under-representation in serum of HIV-1 sequences with predicted CXCR4 usage was sometimes observed implying that the analysis of viral sequences from different sources may provide a more complete assessment of the viral quasispecies in peripheral blood in vivo.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
November 1995, Clinical immunology and immunopathology,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
January 1999, Methods in molecular medicine,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
January 1999, Methods in molecular medicine,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
March 1993, Journal of acquired immune deficiency syndromes,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
February 1997, Clinical and experimental immunology,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
January 2012, Antiviral therapy,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
December 1997, Journal of virological methods,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
January 1991, Archives of virology,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
February 1995, AIDS research and human retroviruses,
Diana Edo-Matas, and Marit J van Gils, and Emma J Bowles, and Marjon Navis, and Andrea Rachinger, and Brigitte Boeser-Nunnink, and Guillaume B Stewart-Jones, and Neeltje A Kootstra, and Angélique B van 't Wout, and Hanneke Schuitemaker
February 1998, The journal of medical investigation : JMI,
Copied contents to your clipboard!